Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants

Clinical trial NCT07283770 · RECRUITING

Trial details

NCT number: NCT07283770
Sponsor: Vertex Pharmaceuticals Incorporated
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2025-12-09
Primary completion: 2026-11-19
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.